NDAORALTABLET, EXTENDED RELEASE
Approved
Jan 2008
Lifecycle
LOE Approaching
Competitive Pressure
15/100
Clinical Trials
20
Data completeness
5/8 — Partial
MOXATAG (amoxicillin) by Pragma Bio is drug. Approved for pneumonia, otitis media, sinusitis and 9 more indications. First approved in 2008.
Drug data last refreshed 20h ago
Mechanism of Action
drug. [see Clinical Pharmacology ()]
Indications (12)
Worked on MOXATAG at Pragma Bio? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.